Department of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
Department of Otolaryngology, Maoming People's Hospital, Maoming, China.
Cancer Causes Control. 2024 Mar;35(3):465-475. doi: 10.1007/s10552-023-01805-9. Epub 2023 Oct 16.
Brain metastasis (BM) is an aggressive complication with an extremely poor prognosis in patients with small-cell lung cancer (SCLC). A well-constructed prognostic model could help in providing timely survival consultation or optimizing treatments.
We analyzed clinical data from SCLC patients between 2000 and 2018 based on the Surveillance, Epidemiology, and End Results (SEER) database. We identified significant prognostic factors and integrated them using a multivariable Cox regression approach. Internal validation of the model was performed through a bootstrap resampling procedure. Model performance was evaluated based on the area under the curve (AUC) and calibration curve.
A total of 2,454 SCLC patients' clinical data was collected from the database. It was determined that seven clinical parameters were associated with prognosis in SCLC patients with BM. A satisfactory level of discrimination was achieved by the predictive model, with 6-, 12-, and 18-month AUC values of 0.726, 0.707, and 0.737 in the training cohort; and 0.759, 0.742, and 0.744 in the validation cohort. As measured by survival rate probabilities, the calibration curve agreed well with actual observations. Furthermore, prognostic scores were found to significantly alter the survival curves of different risk groups. We then deployed the prognostic model onto a website server so that users can access it easily.
In this study, a nomogram and a web-based predictor were developed to predict overall survival in SCLC patients with BM. It may assist physicians in making informed clinical decisions and determining the best treatment plan for each patient.
脑转移(BM)是小细胞肺癌(SCLC)患者一种具有极差预后的侵袭性并发症。一个精心构建的预后模型可以帮助及时提供生存咨询或优化治疗。
我们基于监测、流行病学和最终结果(SEER)数据库分析了 2000 年至 2018 年 SCLC 患者的临床数据。我们确定了有意义的预后因素,并通过多变量 Cox 回归方法对其进行整合。模型的内部验证通过自举重采样程序进行。基于曲线下面积(AUC)和校准曲线评估模型性能。
从数据库中收集了 2454 例 SCLC 患者的临床数据。确定了 7 个临床参数与 SCLC 伴 BM 患者的预后相关。预测模型具有良好的区分能力,在训练队列中,6、12 和 18 个月的 AUC 值分别为 0.726、0.707 和 0.737;在验证队列中,6、12 和 18 个月的 AUC 值分别为 0.759、0.742 和 0.744。从生存率概率来看,校准曲线与实际观察结果吻合良好。此外,预后评分显著改变了不同风险组的生存曲线。然后,我们将预后模型部署到一个网站服务器上,以便用户可以轻松访问它。
在这项研究中,我们开发了一个列线图和一个基于网络的预测器,用于预测 SCLC 伴 BM 患者的总生存。它可以帮助医生做出明智的临床决策,并为每个患者确定最佳的治疗方案。